Gut microbiota and dysbiosis

There has been a growing interest within the medical and scientific community towards the microbial imbalance within the body – dysbiosis. The human gut microbiota provides essential roles in normal physiology for digestion and immunity. However, a microbial imbalance can result in a range of functional gastrointestinal disorders (FGID), cancer and diabetes. FGIDs inflammatory bowel disease (IBD), ulcerative colitis (UC), Crohn’s disease (CD), irritable bowel syndrome (IBS) and non-alcoholic steatohepatitis (NASH).


Analysing gut microbiota

In recent years, the diagnosis and treatment of dysbiosis has been of great interest to the medical and scientific community. Through microbiota research, there have been emerging strategies to treat FGID. The use of pre- and probiotics, antibiotics and faecal microbiota transplants (FMT) is providing new options for patients with chronic digestive disorders.

Tests for dysbiosis

DNA analysis tools for gut microbiota, such as the GA-Map® Dysbiosis Test Lx, can be used to identify and quantify disease severity. Repeated testing also allows clinicians to monitor the composition of the microbiome over time. This means treatment plans can be tailored to patients to alleviate their symptoms, e.g. diarrhoea.

See our tests

Find out more

BIOHIT also provides a microbiota test analysis service

Find out More